SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-129191
Filing Date
2016-06-22
Accepted
2016-06-22 15:12:16
Documents
1
Period of Report
2016-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4987
  Complete submission text file 0001209191-16-129191.txt   6892
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVENIDA DIAGONAL 549, 5TH FLOOR BARCELONA U3 E-08029
Business Address AVENIDA DIAGONAL 549, 5TH FLOOR BARCELONA U3 E-08029 34-93-600-3716
Grupo Ferrer Internacional, S.A. (Reporting) CIK: 0001623398 (see all company filings)

State of Incorp.: U3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51820 | Film No.: 161726539

Mailing Address AVENIDA DIAGONAL 549 5TH FLOOR BARCELONA U3 E-08029
Business Address
Ferrer-Salat Sergio (Reporting) CIK: 0001668295 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51820 | Film No.: 161726538